Swift Creek Health Center in Cary, NC

Swift Creek Health Center is a medicare certified nursing home in Cary, North Carolina. It is located in Wake county at 221 Brightmore Drive, Cary, North Carolina 27511. You can reach out to the office of Swift Creek Health Center via phone at (984) 200-3688. This skilled nursing facility has 28 federally certified beds with average occupancy rate of 56.79%. The nursing facility is classified as "Continuing Care Retirement Community" by CMS and its legal business name is Cary Senior Housing I Opco Llc and has the following ownership type - For Profit - Limited Liability Company.

Swift Creek Health Center (Medicare CCN 345577) is certified by CMS (Centers for Medicare & Medicaid Services) and participates in medicare program. This means if you are part of medicare program, you may consider this nursing facility for your medical needs. It was first certified by CMS in 2020 (4 years certified) and the last quality survey was conducted in November, 2020.

Name	Swift Creek Health Center
Location	221 Brightmore Drive, Cary, North Carolina
Certified By	Medicare
No. of Certified Beds	28
Occupancy Rate	56.79%
Medicare ID (CCN)	345577
Legal Business Name	Cary Senior Housing I Opco Llc
Ownership Type	For Profit - Limited Liability Company

Nursing Homes may have multiple NPI numbers. We have found possible NPI number/s associated with Swift Creek Health Center from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Nursing homes vary in the quality of care and services they provide to their residents. The below quality ratings for Swift Creek Health Center are calculated from three sources - health inspection results, staffing data, and quality measure data. This information gives you an indication of the care Swift Creek Health Center give to their patients.

Ratings from Surveys (Inspections):
Ratings from Quality Measures:
Ratings from Staffing Data:
Overall Rating:

News Archive

Israel President announces launch of new international centre for brain research

On the opening of the ILSI Biomed Israel 2011 week, President Peres has announced the launch of a new international centre in Israel, set to conduct brain research and to promote the neuro-technology field.

TapImmune announces successful conveyance of Investigational New Drug Application from Mayo Clinic

TapImmune, Inc., a clinical stage immunotherapy company, specializing in the development of innovative technologies for the treatment of metastatic cancer, announced today the successful conveyance of the Mayo Clinic IND (Investigational New Drug Application) to TapImmune as part of the recently completed licensing agreement.

John H. Postlethwait selected to receive GSA's George W. Beadle Award

The Genetics Society of America is pleased to announce that John H. Postlethwait, PhD (University of Oregon) has been selected to receive the Society's George W. Beadle Award for outstanding contributions to the community of genetics researchers.

Actavis' Lamictal ODT drug receives FDA approval for treatment of epilepsy and bipolar disorder

Actavis, Inc. (NYSE: ACT) today announced that it has received approval from the U.S. Food and Drug Administration (FDA) on its Abbreviated New Drug Application (ANDA) for Lamotrigine Orally Disintegrating Tablets, 25 mg, 50 mg, 100 mg and 200 mg, a generic equivalent to GlaxoSmithKline's Lamictal® ODT.

Read more Medical News

› Verified 1 days ago

Number of Facility Reported Incidents	0
Number of Substantiated Complaints	0
Number of Fines	0
Total Amount of Fines in Dollars	$0
Number of Payment Denials	0
Total Number of Penalties	0

The resident survey data of Swift Creek Health Center is compared against the national average with the color code indicators: Better than National Average Worse than National Average

Experience Measure	Provider	National Avg.